Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Low Dose Cytarabine and Lintuzumab-Ac225 in Older AML Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2017 by Actinium Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Actinium Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT02575963
First received: October 7, 2015
Last updated: May 22, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2019
  Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)